These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy. Mabru M; Dacher JN; Bauer F Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122 [No Abstract] [Full Text] [Related]
6. Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis. Bucciarelli-Ducci C; Locca D; Barbeau G; Prasad SK Eur Heart J; 2007 May; 28(10):1186. PubMed ID: 17121755 [No Abstract] [Full Text] [Related]
7. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool]. Braun G; Sechtem U; Mahrholdt H Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular trabeculation assessment with cardiac magnetic resonance. Fernández-Golfín C; Gómez JZ J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):477. PubMed ID: 20516804 [No Abstract] [Full Text] [Related]
9. Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension". Schlaich MP; Lambert GW; Lambert EA; Esler MD Circulation; 2007 Oct; 116(17):e416; author reply e417. PubMed ID: 17965398 [No Abstract] [Full Text] [Related]
10. Value of phase-sensitive inversion recovery sequence to perform and analyse late gadolinium enhancement in cardiac amyloidosis. Gerbaud E; Lederlin M; Laurent F Arch Cardiovasc Dis; 2009 Dec; 102(12):859-60. PubMed ID: 19963197 [No Abstract] [Full Text] [Related]
11. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis. Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322 [TBL] [Abstract][Full Text] [Related]
12. [The clinical classification of hypertensive cardiopathy depending on the degree of cardiac involvement]. Iriarte Ezkurdia MM; Murga Eizaga Etxebarria N; Sagastagoitia Gorostiza JD Rev Clin Esp; 1993 Feb; 192(2):86-8. PubMed ID: 8460241 [No Abstract] [Full Text] [Related]
13. [Methods for studying the heart with magnetic resonance]. Bartolozzi C; Casolo GC; Petacchi D; De Dominicis R Radiol Med; 1986 Dec; 72(12):911-6. PubMed ID: 3797711 [TBL] [Abstract][Full Text] [Related]
14. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis. Lyne JC; Petryka J; Pennell DJ Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093 [No Abstract] [Full Text] [Related]
15. Cardiac amyloidosis with giant atria. Cheng Z; Fang Q; Liu Y Heart; 2010 Nov; 96(22):1820. PubMed ID: 20813723 [No Abstract] [Full Text] [Related]
16. [Cardiac amyloidosis]. Eliseev OM Ter Arkh; 1980; 52(12):116-21. PubMed ID: 7017994 [No Abstract] [Full Text] [Related]
17. Magnetic resonance imaging evaluation of surgical ventricular reconstruction. Natori S; Conte JV; Lima JA; Bluemke DA Ann Thorac Surg; 2005 Aug; 80(2):743. PubMed ID: 16039253 [No Abstract] [Full Text] [Related]